Ann: PrIME completes first three trial production, page-7

re: Ann: PrIME completes first three trial pr... It seems to me that regardless of whether this announcement is viewed through the prism of the management sceptics or the glass half full optimists...the inescapable conclusion is that it does validate the IP.
Put another way, from one who vassilates between dismay at the corporate shenanigans of the recent past and then speculative zeal for the opportunities presented by the IP, I think on balance this announcement must be seen as a significant reassurance that progress is being made. Further it provides some evidence that eventually our company will be well placed to meet the health demands and aspirations of a rising middle class throughout Asia.
I agree with Jukes that NSP is simply not on enough radars at present to get a significant bounce, but that provides a real buying opportunity for those few here who have been following the stock.
Regards